- Home
- SVRE vs VERO Comparison
SVRE vs VERO Comparison
Compare SVRE & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- VERO
- Stock Information
- Founded
- SVRE 2014
- VERO N/A
- Country
- SVRE Israel
- VERO Canada
- Employees
- SVRE N/A
- VERO N/A
- Industry
- SVRE
- VERO Medical/Dental Instruments
- Sector
- SVRE
- VERO Health Care
- Exchange
- SVRE Nasdaq
- VERO Nasdaq
- Market Cap
- SVRE 2.6M
- VERO 3.1M
- IPO Year
- SVRE 2022
- VERO N/A
- Fundamental
- Price
- SVRE $0.12
- VERO $0.58
- Analyst Decision
- SVRE
- VERO
- Analyst Count
- SVRE 0
- VERO 0
- Target Price
- SVRE N/A
- VERO N/A
- AVG Volume (30 Days)
- SVRE 5.3M
- VERO 1.4M
- Earning Date
- SVRE 08-27-2024
- VERO 11-13-2024
- Dividend Yield
- SVRE N/A
- VERO N/A
- EPS Growth
- SVRE N/A
- VERO N/A
- EPS
- SVRE N/A
- VERO N/A
- Revenue
- SVRE $458,952.00
- VERO $69,809,000.00
- Revenue This Year
- SVRE N/A
- VERO N/A
- Revenue Next Year
- SVRE $422.52
- VERO $7.56
- P/E Ratio
- SVRE N/A
- VERO N/A
- Revenue Growth
- SVRE N/A
- VERO N/A
- 52 Week Low
- SVRE $0.11
- VERO $0.40
- 52 Week High
- SVRE $1.50
- VERO $2.43
- Technical
- Relative Strength Index (RSI)
- SVRE 29.85
- VERO 55.86
- Support Level
- SVRE $0.11
- VERO $0.44
- Resistance Level
- SVRE $0.13
- VERO $0.49
- Average True Range (ATR)
- SVRE 0.01
- VERO 0.06
- MACD
- SVRE 0.00
- VERO 0.01
- Stochastic Oscillator
- SVRE 24.14
- VERO 74.34
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.